// App-Quantinova.ai

T4303 2015 AHA : Clinical Outcomes of Patients Treated with First Generation vs. Second Generation Drug-eluting Stents for Left Main Coronary Artery Disease: A Meta-analysis

Researchers

Presenter

  • Abel Casso Dominguez

Principal Investigators

  • Chirag Bavishi

  • Jacobo Pena

  • Patricia Chavez

  • Shilpkumar Arora

  • Pedro Moreno

  • Jacqueline Tamis-Holland

Medical Centers

  • Mount Sinai Roosevelt and Mount Sinai St. Lukes, New York, NY

  • Mount Sinai, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Left main disease

  • Coronary artery lesions

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

  • Paclitaxel

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved